Jackson Square Capital LLC Acquires Stake in Johnson & Johnson

The institutional investor purchased 5,275 shares of the pharmaceutical giant's stock.

Apr. 12, 2026 at 9:39am

Got story updates? Submit your updates here. ›

A cinematic close-up image of the heavy, industrial machinery and components that make up the internal workings of a pharmaceutical manufacturing facility, captured in a high-contrast, documentary style that emphasizes the scale, complexity, and power of Johnson & Johnson's production capabilities.

An extreme close-up view of the intricate machinery and components that power Johnson & Johnson's pharmaceutical manufacturing operations, highlighting the company's industrial might and production capabilities.New Brunswick Today

Jackson Square Capital LLC, an institutional investor, has purchased a new stake in Johnson & Johnson (NYSE:JNJ) during the fourth quarter, according to a recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,275 shares of the company's stock, valued at approximately $1,092,000.

Why it matters

Johnson & Johnson is a major pharmaceutical and healthcare company, and changes in institutional ownership of its stock can signal broader investor sentiment and market trends in the sector.

The details

According to the 13F filing, Jackson Square Capital LLC added the new position in Johnson & Johnson shares during the fourth quarter. The purchase represents a new investment for the firm in the healthcare giant.

The shares were purchased during the fourth quarter of the year.

The players